SCHEMBL7288694

SCHEMBL7288694

CN(C)CCCN(C(=O)Cc1ccccc1)c1ccccc1SCc1ccc(Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY2R P49146 6/20 0.61
L3MBTL1 Q9Y468 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PTPRG P23470 1/20 0.40
UTS2R Q9UKP6 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7290591 1.00 NPY2R (0.61) NPY2RL3MBTL1TDP1TSHRSMN1; SMN2
SCHEMBL7290248 0.93 NPY2R (0.69) NPY2RL3MBTL1SMN1; SMN2GAAMAPK1
Oxalic Acid SCHEMBL7291345 0.89 NPY2R (0.63) NPY2RL3MBTL1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL9736552 0.88 NPY2R (0.62) NPY2RL3MBTL1TDP1SMN1; SMN2TP53
SCHEMBL9736030 0.88 NPY2R (0.59) NPY2RSMN1; SMN2GAAALDH1A1KDM4E
SCHEMBL7298617 0.88 NPY2R (0.59) NPY2RSMN1; SMN2GAAALDH1A1KDM4E
SCHEMBL7288507 0.86 NPY2R (0.58) NPY2RL3MBTL1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL7289372 0.85 NPY2R (0.47) NPY2RL3MBTL1TDP1TSHRSMN1; SMN2
SCHEMBL7297873 0.83 NPY2R (0.67) NPY2RSMN1; SMN2TP53GAAMAPK1
SCHEMBL7290237 0.82 NPY2R (0.69) NPY2RL3MBTL1KMT2AMEN1RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 EP claimed
JP-4270220-A None JP disclosed
JP-H04270220-A THERAPEUTIC AGENT FOR CARDIOVASCULAR DISEASE E R SQUIBB & SONS INC 1992-09-25 JP disclosed
US-5116851-A Administering antiischemic and antiarrhythmia agents E. R. SQUIBB & SONS, INC. (US) 1992-05-26 US disclosed
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 EP disclosed